REFERENCES
- Weinstein GD, Frost P: Abnormal cell proliferation in psoriasis. J Invest Dermatol 40:254–259, 1968
- Cullen SI: Topical therapy of psoriasis. Clin Med 73:27–29, 1966
- Goeckerman WH: The treatment of psoriasis. Northwest Med 24:2–9, 1925
- Grupper C: The chemistry, pharmacology, and use of tar in the treatment of psoriasis. In Farber E, Cox A (Editors): Psoriasis. Palo Alto, Calif, Stanford University Press, 1971, p 347
- Perry HO, Soderstrom CW, Schulze RW: The Goeckerman treatment of psoriasis. Arch Dermatol 98:178–182, 1968
- Harris DR, Ferrington RA: The chemistry, pharmacology, and use of anthralin in the treatment of psoriasis. In Farber, Cox (Editors),4 p 357
- Farber EM, Harris DR: Hospital treatment of psoriasis. Arch Dermatol 101:381–389, 1970
- Wilkinson DS: Psoriasis. In Rook A, Wilkinson DS, Ebling F (Editors): Textbook of Dermatology. Philadelphia, FA Davis Company, 1968, p 1088
- Weinstein GD: Biochemical and pathophysiological rationale for amethopterin in psoriasis. Ann NY Acad Sci 186:452–466, 1971
- Weinstein GD, Frost P: Methotrexate for psoriasis. A new therapeutic schedule. Arch Dermatol 103: 33–38, 1971
- Roenigk HH Jr, Fowler-Bergfeld W, Curtis GH: Methotrexate for psoriasis in weekly oral doses. Arch Dermatol 99:86–93, 1969
- Weinstein GD, Cox JW, Suringa DW, et al: Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis. Arch Dermatol 102:613–618, 1970
- Roenigk HH Jr, Maibach HI, Weinstein GD: Use of methotrexate in psoriasis. Arch Dermatol 105: 363–365, 1972